Table 1.
Baseline patient demographics of gene-mediated cytotoxic immunotherapy + standard of care group and standard of care matched control group
| GMCI + SOC N = 48 | SOC N = 134 | Comparison (P value) | |
|---|---|---|---|
| AGE | |||
| <50 y | 13 (27%) | 26 (19%) | .306 |
| ≥50 y | 35 (73%) | 108 (81%) | |
| Median (range) | 57 (32–72) | 60 (24–90) | |
| KPS | |||
| 90–100 | 32 (67%) | 81 (60%) | .491 |
| 70–80 | 16 (33%) | 53 (40%) | |
| Median | 90 | 90 | |
| Tumor Histology | |||
| WHO IV (GBM) | 43 (90%) | 128 (95%) | .162 |
| WHO III (AA, AO) | 5 (10%) | 6 (5%) | |
| Extent of Resection | |||
| Total | 19 (40%) | 47 (35%) | .602 |
| Subtotal | 29 (60%) | 87 (65%) | |